An angiotensin converting enzyme (ACE) inhibitor, Fosinopril is used for the treatment of hypertension and heart failure. It is a prodrug and is converted in vivo to the active form fosinoprilat. Reference standards of Fosinopril API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Fosinopril
Catalogue No.:PA 06 46000
CAS :
Molecular Formula : C30H46NO7P
Molecular Weight : 563.66
((4-Phenylbutyl)phosphinyl acetic acid, Disodium Salt)
Catalogue No.:PA 06 47070
Molecular Formula : C12H15Na2O4P
Molecular Weight : 300.2
Methylphenyl Fosinopril-d5
Catalogue No.:PA STI 064250
Molecular Formula : C37H47D5NO7P
Molecular Weight : 658.82
Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid-d7
Catalogue No.:PA STI 026830
Molecular Formula : C19H22D7O6P
Molecular Weight : 391.45
rac-Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid-d7
Catalogue No.:PA STI 026840
Fosinopril-d5
Catalogue No.:PA STI 043060
Molecular Formula : C30H41D5NO7P
Molecular Weight : 568.69
Fosinopril-d5 Sodium Salt
Catalogue No.:PA STI 043070
Molecular Formula : C30H40D5NNaO7P
Molecular Weight : 590.68
Fosinoprilat-d5 Sodium Salt
Catalogue No.:PA STI 043090
Molecular Formula : C23H28D5NNaO7P
Molecular Weight : 462.51
Fosinopril-d5 Cesium
Catalogue No.:PA STI 043100
Molecular Formula : C30H40D5CsNO7P
Molecular Weight : 700.59
Fosinoprilat-d7
Catalogue No.:PA STI 043110
Molecular Formula : C23H27D7NO5P
Molecular Weight : 442.54
Sodium (2S,4S)-4-cyclohexyl-1-(3-oxopentanoyl)pyrrolidine-2-carboxylate
Catalogue No.:PA 06 47510
Molecular Formula : C16H24NNaO4
Molecular Weight : 317.36
Catalogue No.:PA IPIPRS 120 13
Molecular Formula :
Molecular Weight : NA
Fosinopril impurity mixture (Y0001212)
Catalogue No.:PA EPY0001212
Molecular Formula : NA
Fosinopril sodium (Y0001227)
Catalogue No.:PA EPY0001227
Fosinopril impurity A (Y0001228)
Catalogue No.:PA EPY0001228
Fosinopril impurity B (Y0001229)
Catalogue No.:PA EPY0001229
Fosinopril impurity C (Y0001230)
Catalogue No.:PA EPY0001230
Fosinopril impurity D (Y0001231)
Catalogue No.:PA EPY0001231
Fosinopril impurity I (Y0001232)
Catalogue No.:PA EPY0001232
Fosinopril impurity K (Y0001233)
Catalogue No.:PA EPY0001233
fosinopril sodium (1091RB)
Catalogue No.:PA BP1091RB
fosinopril impurity A (1092RB)
Catalogue No.:PA BP1092RB
fosinopril impurity 1 (1162RB)
Catalogue No.:PA BP1162RB
Fosinopril Related Compound E ((4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl) (1283459)
Catalogue No.:PA USP1283459
Fosinopril Related Compound F ((4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phosph (1283460)
Catalogue No.:PA USP1283460
Fosinopril Related Compound G ((4-phenylbutyl)phosphinyl acetic acid, disodium salt) (1283470)
Catalogue No.:PA USP1283470
Fosinopril Related Compound H (4-phenylbutyl phosphonic acid) (1283481)
Catalogue No.:PA USP1283481
4-Phenybutyl 2-Carboxyethylphosphinic Acid (Fosinopril Impurity)
Catalogue No.:PA 06 47530
Molecular Formula : C12H17O4P
Molecular Weight : 256.23
Sodium (2S,4S)-1-(2-((R)-((S)-2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)-4-phenylpyrrolidine-2-carboxylate
Catalogue No.:PA 06 0461002
Molecular Formula : C30H39NNaO7P
Molecular Weight : 579.61
Sodium (2S,4S)-4-cyclohexyl-1-(2-((R)-(4-phenylbutyl)((S)-1-(propionyloxy)propoxy)phosphoryl)acetyl)pyrrolidine-2-carboxylate
Catalogue No.:PA 06 0461001
Molecular Formula : C29H43NNaO7P
Molecular Weight : 571.63
Sodium 2-(oxido(4-phenylbutyl)phosphoryl)acetate
Catalogue No.:PA 06 0461000
(2S,4S)-4-Cyclohexyl-1-(3-oxopentanoyl)pyrrolidine-2-carboxylic acid
Catalogue No.:PA 06 0471001
Molecular Formula : C16H25NO4
Molecular Weight : 295.38
4-Phenylbutylphosphonic Acid
Catalogue No.:PA 06 0461005
Molecular Formula : C10H15O3P
Molecular Weight : 214.2
Cyclohexyl L-prolinate 3-oxopentanoate
Catalogue No.:PA 06 0461004
Molecular Formula : C16H27NO5
Molecular Weight : 313.39
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
